Kidney involvement in systemic sclerosis Beyond Rheumatology 2019; 1 (1) : e253 DOI: 10.53238_20195_253
Biosimilars: New guns for the treatment of rheumatological patients? Beyond Rheumatology 2019; 1 (1) : e255 DOI: 10.4081/br.2019.3
The journey of canakinumab; on- and off-label indications Beyond Rheumatology 2019; 1 (1) : e256 DOI: 10.4081/br.2019.4